Maravai LifeSciences Holdings, Inc. ( MRVI) - Key Metrics
MRVI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.35 | -$0.08 | $0.03 | $0.02 |
| 2026Q1 | $0.45 | -$0.03 | $0.06 | $0.03 |
| 2025Q4 | $0.34 | -$0.25 | -$0.16 | -$0.17 |
| 2025Q3 | $0.29 | -$0.18 | -$0.10 | -$0.12 |
| 2025Q2 | $0.33 | -$0.27 | -$0.07 | -$0.09 |
MRVI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -19.50 |
| 2026Q1 | 0% | -27.75 |
| 2025Q4 | 0% | -3.25 |
| 2025Q3 | 0% | -3.99 |
| 2025Q2 | 0% | -2.23 |
MRVI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.39% | 0% |
| 2026Q1 | 1.02% | 0% |
| 2025Q4 | -5.28% | 0% |
| 2025Q3 | -4.35% | 0% |
| 2025Q2 | -3.78% | 0% |
MRVI
Price: $7.07
52 week price:
Earnings Per Share: -0.53 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 2.1 billion